NCT05761093 Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment
| NCT ID | NCT05761093 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chinese University of Hong Kong |
| Condition | Prostate Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 306 participants |
| Start Date | 2022-09-07 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 306 participants in total. It began in 2022-09-07 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this study is to examine the preference weightings in term of risk/ benefit attributes of treatment in physician and prostate cancer patients from different stages of disease.
Eligibility Criteria
Inclusion Criteria: * aged 18 years or older, * diagnosis of metastatic prostate cancer within 5 years, * able to read and write, * accepting and signing the informed consent Exclusion Criteria: * if patients are unable to complete the survey by themselves due to physical or psychological reasons, * deemed ineligible by treating physicians if patients are unable to complete the survey by themselves due to physical or psychological reasons, * deemed ineligible by treating physicians
Contact & Investigator
Chi Fai NG, MD
PRINCIPAL INVESTIGATOR
Chinese University of Hong Kong
Frequently Asked Questions
Who can join the NCT05761093 clinical trial?
This trial is open to male participants only, aged 18 Years or older, studying Prostate Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05761093 currently recruiting?
Yes, NCT05761093 is actively recruiting participants. Contact the research team at ngcf@surgery.cuhk.edu.hk for enrollment information.
Where is the NCT05761093 trial being conducted?
This trial is being conducted at Shatin, Hong Kong.
Who is sponsoring the NCT05761093 clinical trial?
NCT05761093 is sponsored by Chinese University of Hong Kong. The principal investigator is Chi Fai NG, MD at Chinese University of Hong Kong. The trial plans to enroll 306 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.